Literature DB >> 30745086

Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.

Jelena Petrovic1, Yeqiao Zhou1, Maria Fasolino2, Naomi Goldman2, Gregory W Schwartz3, Maxwell R Mumbach4, Son C Nguyen2, Kelly S Rome1, Yogev Sela5, Zachary Zapataro1, Stephen C Blacklow6, Michael J Kruhlak7, Junwei Shi8, Jon C Aster9, Eric F Joyce10, Shawn C Little11, Golnaz Vahedi10, Warren S Pear12, Robert B Faryabi13.   

Abstract

Chromatin loops enable transcription-factor-bound distal enhancers to interact with their target promoters to regulate transcriptional programs. Although developmental transcription factors such as active forms of Notch can directly stimulate transcription by activating enhancers, the effect of their oncogenic subversion on the 3D organization of cancer genomes is largely undetermined. By mapping chromatin looping genome-wide in Notch-dependent triple-negative breast cancer and B cell lymphoma, we show that beyond the well-characterized role of Notch as an activator of distal enhancers, Notch regulates its direct target genes by instructing enhancer repositioning. Moreover, a large fraction of Notch-instructed regulatory loops form highly interacting enhancer and promoter spatial clusters termed "3D cliques." Loss- and gain-of-function experiments show that Notch preferentially targets hyperconnected 3D cliques that regulate the expression of crucial proto-oncogenes. Our observations suggest that oncogenic hijacking of developmental transcription factors can dysregulate transcription through widespread effects on the spatial organization of cancer genomes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Notch; breast cancer; gene regulation; genome organization; lymphoma; oncogenic signaling

Year:  2019        PMID: 30745086      PMCID: PMC6485942          DOI: 10.1016/j.molcel.2019.01.006

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

1.  Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation.

Authors:  Guoliang Li; Xiaoan Ruan; Raymond K Auerbach; Kuljeet Singh Sandhu; Meizhen Zheng; Ping Wang; Huay Mei Poh; Yufen Goh; Joanne Lim; Jingyao Zhang; Hui Shan Sim; Su Qin Peh; Fabianus Hendriyan Mulawadi; Chin Thing Ong; Yuriy L Orlov; Shuzhen Hong; Zhizhuo Zhang; Steve Landt; Debasish Raha; Ghia Euskirchen; Chia-Lin Wei; Weihong Ge; Huaien Wang; Carrie Davis; Katherine I Fisher-Aylor; Ali Mortazavi; Mark Gerstein; Thomas Gingeras; Barbara Wold; Yi Sun; Melissa J Fullwood; Edwin Cheung; Edison Liu; Wing-Kin Sung; Michael Snyder; Yijun Ruan
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

2.  Myc Regulates Chromatin Decompaction and Nuclear Architecture during B Cell Activation.

Authors:  Kyong-Rim Kieffer-Kwon; Keisuke Nimura; Suhas S P Rao; Jianliang Xu; Seolkyoung Jung; Aleksandra Pekowska; Marei Dose; Evan Stevens; Ewy Mathe; Peng Dong; Su-Chen Huang; Maria Aurelia Ricci; Laura Baranello; Ying Zheng; Francesco Tomassoni Ardori; Wolfgang Resch; Diana Stavreva; Steevenson Nelson; Michael McAndrew; Adriel Casellas; Elizabeth Finn; Charles Gregory; Brian Glenn St Hilaire; Steven M Johnson; Wendy Dubois; Maria Pia Cosma; Eric Batchelor; David Levens; Robert D Phair; Tom Misteli; Lino Tessarollo; Gordon Hager; Melike Lakadamyali; Zhe Liu; Monique Floer; Hari Shroff; Erez Lieberman Aiden; Rafael Casellas
Journal:  Mol Cell       Date:  2017-08-10       Impact factor: 17.970

3.  Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.

Authors:  Alexander Stoeck; Serguei Lejnine; Andrew Truong; Li Pan; Hongfang Wang; Chongzhi Zang; Jing Yuan; Chris Ware; John MacLean; Philip W Garrett-Engele; Michael Kluk; Jason Laskey; Brian B Haines; Christopher Moskaluk; Leigh Zawel; Stephen Fawell; Gary Gilliland; Theresa Zhang; Brandon E Kremer; Birgit Knoechel; Bradley E Bernstein; Warren S Pear; X Shirley Liu; Jon C Aster; Sriram Sathyanarayanan
Journal:  Cancer Discov       Date:  2014-08-07       Impact factor: 39.397

4.  Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements.

Authors:  Maxwell R Mumbach; Ansuman T Satpathy; Evan A Boyle; Chao Dai; Benjamin G Gowen; Seung Woo Cho; Michelle L Nguyen; Adam J Rubin; Jeffrey M Granja; Katelynn R Kazane; Yuning Wei; Trieu Nguyen; Peyton G Greenside; M Ryan Corces; Josh Tycko; Dimitre R Simeonov; Nabeela Suliman; Rui Li; Jin Xu; Ryan A Flynn; Anshul Kundaje; Paul A Khavari; Alexander Marson; Jacob E Corn; Thomas Quertermous; William J Greenleaf; Howard Y Chang
Journal:  Nat Genet       Date:  2017-09-25       Impact factor: 38.330

5.  Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains.

Authors:  Ann Boija; Isaac A Klein; Benjamin R Sabari; Alessandra Dall'Agnese; Eliot L Coffey; Alicia V Zamudio; Charles H Li; Krishna Shrinivas; John C Manteiga; Nancy M Hannett; Brian J Abraham; Lena K Afeyan; Yang E Guo; Jenna K Rimel; Charli B Fant; Jurian Schuijers; Tong Ihn Lee; Dylan J Taatjes; Richard A Young
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

6.  A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development.

Authors:  Peter Mulligan; Fajun Yang; Luisa Di Stefano; Jun-Yuan Ji; Jian Ouyang; Joy L Nishikawa; Debra Toiber; Madhura Kulkarni; Qun Wang; S Hani Najafi-Shoushtari; Raul Mostoslavsky; Steven P Gygi; Grace Gill; Nicholas J Dyson; Anders M Näär
Journal:  Mol Cell       Date:  2011-05-19       Impact factor: 17.970

7.  p300 acts as a transcriptional coactivator for mammalian Notch-1.

Authors:  F Oswald; B Täuber; T Dobner; S Bourteele; U Kostezka; G Adler; S Liptay; R M Schmid
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 8.  The Varied Roles of Notch in Cancer.

Authors:  Jon C Aster; Warren S Pear; Stephen C Blacklow
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

9.  Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.

Authors:  Yumi Yashiro-Ohtani; Hongfang Wang; Chongzhi Zang; Kelly L Arnett; Will Bailis; Yugong Ho; Birgit Knoechel; Claudia Lanauze; Lumena Louis; Katherine S Forsyth; Sujun Chen; Yoonjie Chung; Jonathan Schug; Gerd A Blobel; Stephen A Liebhaber; Bradley E Bernstein; Stephen C Blacklow; Xiaole Shirley Liu; Jon C Aster; Warren S Pear
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

10.  Type II transmembrane serine protease gene variants associate with breast cancer.

Authors:  Kaisa Luostari; Jaana M Hartikainen; Maria Tengström; Jorma J Palvimo; Vesa Kataja; Arto Mannermaa; Veli-Matti Kosma
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

View more
  34 in total

1.  EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.

Authors:  Yeqiao Zhou; Jelena Petrovic; Jingru Zhao; Wu Zhang; Ashkan Bigdeli; Zhen Zhang; Shelley L Berger; Warren S Pear; Robert B Faryabi
Journal:  Mol Cell       Date:  2022-02-18       Impact factor: 17.970

2.  Master lineage transcription factors anchor trans mega transcriptional complexes at highly accessible enhancer sites to promote long-range chromatin clustering and transcription of distal target genes.

Authors:  Shannon M White; Michael P Snyder; Chunling Yi
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

3.  Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression.

Authors:  Maria Fasolino; Naomi Goldman; Wenliang Wang; Benjamin Cattau; Yeqiao Zhou; Jelena Petrovic; Verena M Link; Allison Cote; Aditi Chandra; Michael Silverman; Eric F Joyce; Shawn C Little; Klaus H Kaestner; Ali Naji; Arjun Raj; Jorge Henao-Mejia; Robert B Faryabi; Golnaz Vahedi
Journal:  Immunity       Date:  2020-02-11       Impact factor: 31.745

Review 4.  Tales from topographic oceans: topologically associated domains and cancer.

Authors:  Moray J Campbell
Journal:  Endocr Relat Cancer       Date:  2019-11       Impact factor: 5.678

5.  Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers.

Authors:  Yanli Liu; Bingqian Guo; Estrella Aguilera-Jimenez; Vivian S Chu; Jin Zhou; Zhong Wu; Joshua M Francis; Xiaojun Yang; Peter S Choi; Swneke D Bailey; Xiaoyang Zhang
Journal:  Cancer Res       Date:  2020-10-28       Impact factor: 12.701

6.  p53 mediates target gene association with nuclear speckles for amplified RNA expression.

Authors:  Katherine A Alexander; Allison Coté; Son C Nguyen; Liguo Zhang; Omid Gholamalamdari; Paula Agudelo-Garcia; Enrique Lin-Shiao; K M A Tanim; Joan Lim; Nicolas Biddle; Margaret C Dunagin; Charly R Good; Mariel R Mendoza; Shawn C Little; Andrew Belmont; Eric F Joyce; Arjun Raj; Shelley L Berger
Journal:  Mol Cell       Date:  2021-04-05       Impact factor: 17.970

Review 7.  Remodeling the chromatin landscape in T lymphocytes by a division of labor among transcription factors.

Authors:  Golnaz Vahedi
Journal:  Immunol Rev       Date:  2021-01-15       Impact factor: 12.988

Review 8.  Determinants and role of chromatin organization in acute leukemia.

Authors:  Celestia Fang; Sridhar Rao; John D Crispino; Panagiotis Ntziachristos
Journal:  Leukemia       Date:  2020-07-20       Impact factor: 11.528

Review 9.  Deciphering the Complexity of 3D Chromatin Organization Driving Lymphopoiesis and Lymphoid Malignancies.

Authors:  Laurianne Scourzic; Eralda Salataj; Effie Apostolou
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

10.  ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.

Authors:  Zhendong Cao; Krista A Budinich; Hua Huang; Diqiu Ren; Bin Lu; Zhen Zhang; Qingzhou Chen; Yeqiao Zhou; Yu-Han Huang; Fatemeh Alikarami; Molly C Kingsley; Alexandra K Lenard; Aoi Wakabayashi; Eugene Khandros; Will Bailis; Jun Qi; Martin P Carroll; Gerd A Blobel; Robert B Faryabi; Kathrin M Bernt; Shelley L Berger; Junwei Shi
Journal:  Mol Cell       Date:  2021-08-05       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.